PT1146874E - Antagonista de receptor da vitronectina - Google Patents
Antagonista de receptor da vitronectinaInfo
- Publication number
- PT1146874E PT1146874E PT99960647T PT99960647T PT1146874E PT 1146874 E PT1146874 E PT 1146874E PT 99960647 T PT99960647 T PT 99960647T PT 99960647 T PT99960647 T PT 99960647T PT 1146874 E PT1146874 E PT 1146874E
- Authority
- PT
- Portugal
- Prior art keywords
- receptor antagonist
- vitronectin receptor
- vitronectin
- antagonist
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11090398P | 1998-12-04 | 1998-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1146874E true PT1146874E (pt) | 2005-02-28 |
Family
ID=22335565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99960647T PT1146874E (pt) | 1998-12-04 | 1999-12-03 | Antagonista de receptor da vitronectina |
Country Status (39)
Country | Link |
---|---|
US (1) | US6495560B1 (pt) |
EP (1) | EP1146874B1 (pt) |
JP (1) | JP4481504B2 (pt) |
KR (1) | KR100620485B1 (pt) |
CN (1) | CN1147300C (pt) |
AP (1) | AP1534A (pt) |
AR (1) | AR035006A1 (pt) |
AT (1) | ATE277043T1 (pt) |
AU (1) | AU754408B2 (pt) |
BG (1) | BG65118B1 (pt) |
BR (1) | BR9915879A (pt) |
CA (1) | CA2353415A1 (pt) |
CO (1) | CO5150166A1 (pt) |
CZ (1) | CZ20011963A3 (pt) |
DE (1) | DE69920518T2 (pt) |
DK (1) | DK1146874T3 (pt) |
DZ (1) | DZ2954A1 (pt) |
EA (1) | EA003254B1 (pt) |
EG (1) | EG24025A (pt) |
ES (1) | ES2229798T3 (pt) |
HK (1) | HK1042037B (pt) |
HU (1) | HUP0104804A3 (pt) |
ID (1) | ID28811A (pt) |
IL (2) | IL143390A0 (pt) |
MA (1) | MA25265A1 (pt) |
NO (1) | NO318895B1 (pt) |
NZ (1) | NZ511876A (pt) |
OA (1) | OA11724A (pt) |
PE (1) | PE20001563A1 (pt) |
PL (1) | PL195973B1 (pt) |
PT (1) | PT1146874E (pt) |
SI (1) | SI1146874T1 (pt) |
SK (1) | SK7452001A3 (pt) |
TR (1) | TR200101654T2 (pt) |
TW (1) | TW482673B (pt) |
UA (1) | UA71586C2 (pt) |
UY (1) | UY25824A1 (pt) |
WO (1) | WO2000033838A1 (pt) |
ZA (1) | ZA200104398B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY26780A1 (es) | 2000-06-15 | 2002-01-31 | Pharmacia Corp | Cicloalquil avb3 antagonistas |
DE60118025T2 (de) * | 2000-10-24 | 2006-11-23 | Merck & Co., Inc. | Dibenzoxazepin-alpha-v-integrin-rezeptorantagonist |
CA2436130A1 (en) | 2001-01-29 | 2002-08-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
BR0316876A (pt) | 2002-12-20 | 2005-10-25 | Pharmacia Corp | Compostos de tiazol e composição farmacêutica compreendendo o mesmo |
GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
EP1841406A4 (en) * | 2004-12-21 | 2008-06-25 | Smithkline Beecham Corp | METHOD AND FORMULATIONS |
UA109786C2 (xx) | 2010-07-14 | 2015-10-12 | Гетероциклічні сполуки як агоністи ір-рецептора | |
AR089698A1 (es) | 2012-01-13 | 2014-09-10 | Novartis Ag | Compuestos heterociclicos antagonistas del receptor ip |
ES2637719T3 (es) | 2013-02-13 | 2017-10-16 | Novartis Ag | Compuestos heterocíclicos agonistas del receptor IP |
JP6215335B2 (ja) | 2013-09-24 | 2017-10-18 | 富士フイルム株式会社 | 新規な含窒素化合物もしくはその塩またはそれらと金属との錯体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687154B1 (fr) | 1992-02-07 | 1995-05-12 | Rhone Poulenc Rorer Sa | Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent. |
ATE238996T1 (de) | 1995-06-29 | 2003-05-15 | Smithkline Beecham Corp | Integrin-rezeptor-antagonisten |
AU4109297A (en) * | 1996-09-27 | 1998-04-17 | Merkler, H. | Tank for liquids, particularly for chemically aggressive liquids |
EP0946180A4 (en) | 1996-10-07 | 2003-07-23 | Smithkline Beecham Corp | METHODS FOR STIMULATING BONE FORMATION |
UY24949A1 (es) | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
-
1999
- 1999-03-12 UA UA2001063754A patent/UA71586C2/uk unknown
- 1999-11-29 TW TW088120752A patent/TW482673B/zh not_active IP Right Cessation
- 1999-11-29 UY UY25824A patent/UY25824A1/es unknown
- 1999-11-30 CO CO99075061A patent/CO5150166A1/es unknown
- 1999-11-30 PE PE1999001197A patent/PE20001563A1/es not_active Application Discontinuation
- 1999-12-01 DZ DZ990254A patent/DZ2954A1/xx active
- 1999-12-02 EG EG154299A patent/EG24025A/xx active
- 1999-12-02 AR ARP990106128A patent/AR035006A1/es unknown
- 1999-12-03 CN CNB998159735A patent/CN1147300C/zh not_active Expired - Fee Related
- 1999-12-03 CZ CZ20011963A patent/CZ20011963A3/cs unknown
- 1999-12-03 IL IL14339099A patent/IL143390A0/xx active IP Right Grant
- 1999-12-03 NZ NZ511876A patent/NZ511876A/xx unknown
- 1999-12-03 US US09/857,316 patent/US6495560B1/en not_active Expired - Lifetime
- 1999-12-03 DE DE69920518T patent/DE69920518T2/de not_active Expired - Lifetime
- 1999-12-03 AU AU17502/00A patent/AU754408B2/en not_active Ceased
- 1999-12-03 WO PCT/US1999/028662 patent/WO2000033838A1/en active IP Right Grant
- 1999-12-03 ID IDW00200101183A patent/ID28811A/id unknown
- 1999-12-03 PT PT99960647T patent/PT1146874E/pt unknown
- 1999-12-03 SI SI9930700T patent/SI1146874T1/xx unknown
- 1999-12-03 PL PL99348702A patent/PL195973B1/pl not_active IP Right Cessation
- 1999-12-03 TR TR2001/01654T patent/TR200101654T2/xx unknown
- 1999-12-03 JP JP2000586330A patent/JP4481504B2/ja not_active Expired - Fee Related
- 1999-12-03 DK DK99960647T patent/DK1146874T3/da active
- 1999-12-03 ES ES99960647T patent/ES2229798T3/es not_active Expired - Lifetime
- 1999-12-03 AT AT99960647T patent/ATE277043T1/de not_active IP Right Cessation
- 1999-12-03 HU HU0104804A patent/HUP0104804A3/hu unknown
- 1999-12-03 EA EA200100618A patent/EA003254B1/ru not_active IP Right Cessation
- 1999-12-03 BR BR9915879-5A patent/BR9915879A/pt not_active Application Discontinuation
- 1999-12-03 KR KR1020017006937A patent/KR100620485B1/ko not_active IP Right Cessation
- 1999-12-03 CA CA002353415A patent/CA2353415A1/en not_active Abandoned
- 1999-12-03 EP EP99960647A patent/EP1146874B1/en not_active Expired - Lifetime
- 1999-12-03 SK SK745-2001A patent/SK7452001A3/sk unknown
- 1999-12-03 OA OA1200100139A patent/OA11724A/en unknown
- 1999-12-03 AP APAP/P/2001/002156A patent/AP1534A/en active
-
2001
- 2001-05-24 IL IL143390A patent/IL143390A/en not_active IP Right Cessation
- 2001-05-29 ZA ZA200104398A patent/ZA200104398B/en unknown
- 2001-06-01 MA MA26218A patent/MA25265A1/fr unknown
- 2001-06-01 NO NO20012732A patent/NO318895B1/no not_active IP Right Cessation
- 2001-06-26 BG BG105651A patent/BG65118B1/bg unknown
-
2002
- 2002-02-27 HK HK02101522.3A patent/HK1042037B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712248A (pt) | Antagonista receptores de vitronectina | |
IS5706A (is) | Adenosín A3 viðtakastillar | |
BR9508178A (pt) | Antagonistas de receptor de vitronectina | |
BR9612327A (pt) | Antagonistas receptores de vitronectina | |
BR9612378A (pt) | Antagonistas receptores de vitronectina | |
NO993350D0 (no) | Vitronectin-reseptor-antagonister | |
DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
NO20001514D0 (no) | Vitronectin-reseptor-antagonist | |
NO20004503D0 (no) | Vitronectin-reseptor-antagonister | |
NO20001515D0 (no) | Vitronektin reseptor-antagonist | |
NO20013997L (no) | Reseptoranalyse | |
ID24726A (id) | Antagonis-antagonis reseptor trombin | |
NO20001407D0 (no) | Vitronectin-reseptor-antagonister | |
PT1146874E (pt) | Antagonista de receptor da vitronectina | |
DZ2322A1 (fr) | Antagonistes de récepteurs de vitronectine. | |
DE60033145D1 (de) | Il-8 rezeptorantagonist | |
PT1218005E (pt) | Antagonistas do receptor de vitronectina | |
NO20021295L (no) | Nikotinsyreacetylcholin-reseptor | |
NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
NO20010353L (no) | IL-8 reseptor-antagonist | |
DE69830671D1 (de) | Integrin-rezeptor-antagonisten | |
DK1218005T3 (da) | Vitronectinreptorantagonister |